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ARTICLE
Ad4BP/SF-1 regulates cholesterol synthesis to
boost the production of steroids
Takashi Baba1,2, Hiroyuki Otake1, Miki Inoue2, Tetsuya Sato3, Yasuhiro Ishihara4, Ju-Yeon Moon5,
Megumi Tsuchiya6, Kanako Miyabayashi1, Hidesato Ogawa6, Yuichi Shima1,2,7, Lixiang Wang8, Ryuichiro Sato9,
Takeshi Yamazaki4, Mikita Suyama3, Masatoshi Nomura8,10, Man Ho Choi5, Yasuyuki Ohkawa11 &
Ken-ichirou Morohashi1,2
Housekeeping metabolic pathways such as glycolysis are active in all cell types. In addition,
many types of cells are equipped with cell-specific metabolic pathways. To properly perform
their functions, housekeeping and cell-specific metabolic pathways must function coopera-
tively. However, the regulatory mechanisms that couple metabolic pathways remain largely
unknown. Recently, we showed that the steroidogenic cell-specific nuclear receptor Ad4BP/
SF-1, which regulates steroidogenic genes, also regulates housekeeping glycolytic genes.
Here, we identify cholesterogenic genes as the targets of Ad4BP/SF-1. Further, we reveal that
Ad4BP/SF-1 regulates Hummr, a candidate mediator of cholesterol transport from endo-
plasmic reticula to mitochondria. Given that cholesterol is the starting material for ster-
oidogenesis and is synthesized from acetyl-CoA, which partly originates from glucose, our
results suggest that multiple biological processes involved in synthesizing steroid hormones
are governed by Ad4BP/SF-1. To our knowledge, this study provides the first example where
housekeeping and cell-specific metabolism are coordinated at the transcriptional level.
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Steroid hormones vital for diverse biological processesare synthesized from cholesterol through multi-step reac-tions1–4. Steroidogenesis is active only in functionally spe-
cialized steroidogenic cells, such as adrenocortical and testicular
Leydig cells. Multiple studies have established that all steroido-
genic genes are regulated by the steroidogenic cell-specific tran-
scription factor Ad4BP/SF-1 (NR5A1), which binds them
directly5–8. Recently, we showed that this transcription factor also
directly regulates nearly all glycolytic genes, and thus also governs
the expression of genes involved in housekeeping metabolism9. At
that time, however, we could not determine why this steroido-
genic cell-specific transcription factor regulates two apparently
independent metabolic pathways, steroidogenesis and glycolysis.
Because cholesterol is an essential component of all cells, its
cellular levels are maintained within a narrow range by a complex
control system that balances incorporation, excretion, de novo
synthesis, and consumption10–12. This control machinery is
unique in that sensing of intracellular cholesterol concentration
regulates proteolytic cleavage of the membrane-bound inactive
form of a transcription factor, SREBP-2 (sterol-responsive ele-
ment binding protein-2), into its active soluble form. Following
proteolysis, the soluble form of SREBP-2 translocates into the
nucleus to directly activate many cholesterogenic genes11.
In addition to its role as a key component of cellular mem-
branes, cholesterol is used as the starting material for ster-
oidogenesis in steroidogenic cells1–3. Therefore, it is reasonable
that steroidogenic cells would have a unique mechanism for
meeting their augmented need for cholesterol. Indeed, it was
reported that steroidogenic cells primarily use intracellular cho-
lesterol stores for steroidogenesis in response to steroidogenic
stimulation. Then, after the cholesterol stores decreased rapidly,
de novo cholesterogenesis is activated and the synthesized cho-
lesterol is used for steroidogenesis13. As mentioned above,
Ad4BP/SF-1 regulates the genes implicated in both glycolytic and
steroidogenic pathways. Given that pyruvate, the final product of
glycolysis, can be converted to acetyl-CoA, the starting material
for cholesterogenesis, we hypothesize that the glycolytic and
steroidogenic pathways might be connected via the cholestero-
genic pathway. Given the interconnections among these three
metabolic pathways, we predict that Ad4BP/SF-1 would also
regulate cholesterogenic genes, thereby collectively governing all
metabolic processes from the one that utilizes glucose to the one
that produces steroid hormones (Supplementary Fig. 1).
Results
Indirect regulation of cholesterogenic genes by Ad4BP/SF-1.
To explore the possibility that Ad4BP/SF-1 is involved in choles-
terogenic gene regulation, we obtained the transcriptomes of Y-1
cells, which are derived from a mouse adrenocortical tumor. The
mRNA-seq data revealed that expression of 16 out of 20 choles-
terogenic genes decreased below 70% of control levels in Ad4BP/
SF-1 knockdown cells (Supplementary Fig. 2a). Consistent with the
transcriptome data, quantitative RT-PCR (qRT-PCR) confirmed
that the cholesterogenic genes, with the exception of Tm7sf2, were
down-regulated by the knockdown (Fig. 1a, Supplementary
Fig. 2b). Cyclic AMP (cAMP) stimulates steroidogenic gene
expression4. Hence, we investigated whether cholesterogenic gene
expression is activated by cAMP. Indeed, we found that expression
of many cholesterogenic genes was increased by cAMP stimulation
(Fig. 1a). In Ad4BP/SF-1 knockdown cells, the cAMP-induced up-
regulation of cholesterogenic genes (except for Tm7sf2 and
Hsd17b7) was reduced (Fig. 1a).
We next investigated whether similar knockdown effects would
be observed in steroidogenic Leydig cells prepared from mouse
testes. When these cells were cultured in the absence of cAMP,
transcriptome analysis and qRT-PCR revealed that cholesterogenic
genes were not collectively down-regulated by Ad4BP/SF-1
knockdown (Supplementary Fig. 3a and b). However, when the
expression of these genes was activated by cAMP, they were mostly
down-regulated by the knockdown (Supplementary Fig. 3a and b).
Together, these findings suggest that Ad4BP/SF-1 is implicated in
transcriptional regulation of nearly all cholesterogenic genes in
adrenocortical Y-1 and cAMP-stimulated testicular Leydig cells.
SREBP-2, encoded by Srebf2, is a key regulator of cholestero-
genic gene transcription11. Because a chromatin
immunoprecipitation-sequencing (ChIP-seq) data set for
SREBP-2 obtained from hepatocyte was available14, we investi-
gated whether SREBP-2 ChIP peaks are present in cholestero-
genic genes. Indeed, SREBP-2 ChIP peaks were detected in all
cholesterogenic genes (Supplementary Fig. 4). Furthermore,
Srebf2 was down-regulated by Ad4BP/SF-1 knockdown (Fig. 1b,
Supplementary Fig. 5a and b). Cholesterogenic genes are up-
regulated by SREBP-2 activated in response to a lowered
intracellular cholesterol level10–12. Thus, we expected that the
decreased expression of Srebf2 leads to a reduction in active
SREBP-2 protein, irrespective of intracellular cholesterol con-
tents, and as a consequence, cholesterogenic genes are down-
regulated. Indeed, Srebf2 knockdown (Supplementary Fig. 5c)
resulted in down-regulation of many (17 out of 20) cholestero-
genic genes in Y-1 cells (Fig. 1c, Supplementary Fig. 5d). These
results raise the possibility that Ad4BP/SF-1 controls cholestero-
genic genes indirectly by regulating Srebf2 transcription.
Direct regulation of cholesterogenic genes by Ad4BP/SF-1. In
addition to the indirect regulation described above, it still remains
the possibility that Ad4BP/SF-1 directly regulates cholesterogenic
genes. To explore this possibility, we examined previously pub-
lished ChIP-seq data sets obtained from Y-1 cells9 to ask whether
Ad4BP/SF-1 binds directly to cholesterogenic genes. In addition,
we obtained new Ad4BP/SF-1 ChIP-seq data sets from cAMP-
treated or cAMP-untreated Leydig cells. We found that Ad4BP/
SF-1 bound to many cholesterogenic genes (11 out of 20 in Y-1,
and 12 out of 20 in cAMP-treated and cAMP-untreated Leydig
cells) (Fig. 2a, Supplementary Fig. 4, Supplementary Table 1).
Accumulation of Ad4BP/SF-1 was confirmed by chromatin
immunoprecipitation-quantitative PCR (ChIP-qPCR) (Fig. 2b).
As expected, all ChIP-peak regions contained single or multiple
consensus binding sequences of Ad4BP/SF-1, and at least one
binding sequence was conserved in the corresponding regions of
the human genes (Supplementary Table 1). We next investigated
whether the ChIP-peak regions are associated with transcriptional
activity, using luciferase reporter genes containing the ChIP-peak
regions and promoters of Fdps, Fdft1, Msmo1, and Dhcr24. These
regions exhibited transcriptional activity in Y-1 cells, and their
activity was suppressed by Ad4BP/SF-1 knockdown (Fig. 2c).
Consistent with this, the reporter genes were activated in non-
steroidogenic HeLa cells by ectopically expressed Ad4BP/SF-1 in
a dose-dependent manner, suggesting that a number of choles-
terogenic genes are directly regulated by Ad4BP/SF-1 (Fig. 2d).
Cooperative regulation by Ad4BP/SF-1 and SREBP-2. The
locations of the ChIP peaks of SREBP-2 and Ad4BP/SF-1
exhibited distinct features: the former accumulated near the
transcription initiation sites (putative promoter regions) of all
cholesterogenic genes (Supplementary Fig. 4), whereas the latter
tended to accumulate far from the promoters. Hence, we inves-
tigated the functional correlation between Ad4BP/SF-1 and
SREBP-2. Similar to Ad4BP/SF-1, SREBP-2 alone activated the
reporter gene transcription (Fig. 3a). Moreover, these two factors
cooperatively activated the reporter genes (Fig. 3a). In regard to
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the mechanism underlying the cooperative action of Ad4BP/SF-1
and SREBP-2, we hypothesized that the two transcription factors
physically interact. When purified FLAG-tagged SREBP-2 was
incubated with Y-1 cell nuclear extract, and the mixture was
subjected to immunoprecipitation with an anti-FLAG antibody,
the immunoprecipitates contained Ad4BP/SF-1 (Fig. 3b). More-
over, direct protein–protein interaction was confirmed by an
in vitro binding experiment using purified FLAG-Ad4BP/SF-1
and HA-SREBP-2 (Fig. 3c). Together, these findings indicate that
Ad4BP/SF-1 regulates nearly all cholesterogenic genes in two
ways: direct regulation in cooperation with SREBP-2, and indirect
regulation through transcriptional induction of the Srebf2 gene
(Fig. 3d).
Cholesterogenesis reduced by Ad4BP/SF-1 knockdown. These
observations raised the possibility that Ad4BP/SF-1 knockdown
decreases cholesterogenic activity. To measure activity, we cul-
tured Y-1 cells in medium containing 14C-acetate, and then
determined the amount of de novo synthesized 14C-cholesterol.
As expected, the amount of 14C-cholesterol was decreased to 66%
of control levels in Ad4BP/SF-1 knockdown cells (Fig. 4a). Con-
sistent with this, the amount of cellular cholesterol was mildly
(~15%) decreased by Ad4BP/SF-1 knockdown (Fig. 4b). The
levels of the intermediate products lanosterol, desmosterol, and 7-
dehydrocholesterol were decreased by the knockdown, whereas
the level of lathosterol was unaffected. The level of cholesteryl-
arachidonate, the major cholesteryl ester in the adrenal cortex15,
also decreased, whereas the level of cholesteryl-myristate was not
changed. Together, these findings indicate that Ad4BP/SF-1
knockdown reduced cholesterol synthesis through the expression
of cholesterogenic genes.
Cholesterogenesis and steroidogenesis bridged by Ad4BP/SF-1.
If the glycolytic and steroidogenic pathways are connected via the
cholesterogenic pathway, Ad4BP/SF-1 may govern multiple
metabolic pathways from glycolysis to steroidogenesis. To test
this hypothesis, two gaps between the metabolic pathways
remained to be bridged.
The first of these gaps is between cholesterogenesis and
steroidogenesis. In steroidogenic cells, cholesterol is supplied via
de novo cholesterogenesis and receptor-mediated endocytosis of
low-density and high-density lipoproteins13,16–18. Ldlr and
Scarb1 encode the receptors responsible for the endocytosis of
low-density and high-density lipoproteins, respectively. Similar to
b c
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Fig. 1 Cholesterogenic gene expression affected by Ad4BP/SF-1 knockdown. a Cholesterogenic gene expression in Ad4BP/SF-1 knockdown or control Y-1
cells in the absence or presence of cAMP was determined by qRT-PCR. Bars with “*” are compared to siControl-treated cells. *p < 0.05, **p < 0.01. Bars
with an “¶” are compared to vehicle-treated cells; ¶p < 0.05, ¶¶p < 0.01. b Srebf2 expression was determined in Ad4BP/SF-1 knockdown or control Y-1 cells
by qRT-PCR. *p < 0.01. c Cholesterogenic gene expression was determined in Srebf2 knockdown or control Y-1 cells by qRT-PCR. *p < 0.05, **p < 0.025,
***p < 0.005. a–c Average values with SDs (n= 3) are indicated. Tuba1a was used as a negative control. The values for the siControl-treated cells were
normalized to 1.0
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the cholesterogenic genes, mRNA-seq studies showed that the
expression of these receptor genes was decreased by Ad4BP/SF-1
knockdown, whereas that of genes related to excretion of
cholesterol (Abca1 and Abcg1)19,20 was not altered (Supplemen-
tary Fig. 6a). The endocytosed lipoproteins are hydrolyzed in
lysosomes, and then cholesterol is transported to endoplasmic
reticula21, where the final reaction of cholesterogenesis takes
place. Because CYP11A1, which catalyzes the initial reaction of
steroidogenesis, is localized in the mitochondrial inner mem-
brane22, cholesterol must be transported from endoplasmic
reticula to the mitochondrial inner membrane. This transport
consists of two steps: first from endoplasmic reticula to
mitochondrial outer membrane, and the second from the outer
membrane to inner membrane22. The STAR protein mediates the
transport of cholesterol from mitochondrial outer membrane to
inner membrane, and the encoding gene is regulated by Ad4BP/
SF-123.
Importantly, HUMMR (hypoxia up-regulated mitochondrial
movement regulator, also called MGARP or OSAP) was identified
recently as a plausible candidate for the mediator of cholesterol
transport from endoplasmic reticula to mitochondrial outer
membrane24. Therefore, we investigated whether Ad4BP/SF-1
regulates the Hummr gene. qRT-PCR and mRNA-seq revealed
that Hummr expression was decreased by Ad4BP/SF-1 knock-
down in both Y-1 and Leydig cells, irrespective of cAMP
treatment (Fig. 5a, Supplementary Fig. 6b, c). Furthermore, ChIP-
seq revealed a clear Ad4BP/SF-1 peak at the Hummr locus in both
Y-1 and Leydig cells (Fig. 5b). The accumulation of Ad4BP/SF-1
on the Hummr locus was confirmed by ChIP-qPCR (Fig. 5c). In
addition, activity of a luciferase reporter gene carrying the ChIP-
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peak and promoter region of Hummr was suppressed by Ad4BP/
SF-1 knockdown (Fig. 5d, Supplementary Fig. 6d) and activated
by ectopically expressed Ad4BP/SF-1 in a dose-dependent
manner (Fig. 5e), indicating that the Hummr gene is regulated
by Ad4BP/SF-1 via the ChIP-peak region.
Given that Ad4BP/SF-1 regulates Hummr gene, Ad4BP/SF-1
knockdown should reduce the amount of mitochondrial choles-
terol. Accordingly, we determined the amount of mitochondrial
cholesterol in knockdown Y-1 cells, and found that it was indeed
reduced to approximately 60% of control levels in the knockdown
cells (Fig. 5f). Furthermore, overexpression of HUMMR in
Ad4BP/SF-1 knockdown cells markedly increased mitochondrial
cholesterol (Fig. 5f), suggesting that the decrease was primarily
due to reduced expression of Hummr. These results suggest that
Ad4BP/SF-1 bridges the gap between the cholesterogenic and
steroidogenic pathways by regulating Hummr, which has been
implicated in cholesterol trafficking from endoplasmic reticula to
mitochondria.
Glycolysis and cholesterogenesis bridged by Ad4BP/SF-1. Next,
we examined the involvement of Ad4BP/SF-1 in the regulation of
the genes bridging the second gap between glycolysis and cho-
lesterogenesis. The end product of glycolysis, pyruvate, is con-
verted to cytosolic acetyl-CoA, which is a starting material for
cholesterogenesis. At least nine genes encoding enzymes or
transporters are involved in this conversion (Supplementary
Fig. 7a). According to the transcriptome data, the expression of
most, if not all, of these genes was affected by Ad4BP/SF-1
knockdown, suggesting that many of them are the potential tar-
gets of Ad4BP/SF-1 (Supplementary Fig. 7b). Among them,
ACLY (ATP citrate lyase) has been established as a key enzyme
for the synthesis of cytosolic acetyl-CoA25, and its expression is
regulated by SREBP-226. Hence, we investigated Acly as a
potential target of Ad4BP/SF-1 in steroidogenic cells. The ChIP-
seq data demonstrated that Ad4BP/SF-1 accumulated in the Acly
locus (Supplementary Fig. 8a), which was confirmed by ChIP-
qPCR (Supplementary Fig. 8b). Consistent with this, Acly
expression was decreased by Ad4BP/SF-1 knockdown (Supple-
mentary Fig. 8c). We then examined the transcription activity of
the peak region using reporter gene assays. Reporter gene activity
was suppressed by Ad4BP/SF-1 knockdown (Supplementary
Fig. 8d), and activated by overexpression of Ad4BP/SF-1 in a
dose-dependent manner (Supplementary Fig. 8e). Together, these
results suggest that Acly is a target gene of Ad4BP/SF-1. Given
that ACLY is crucial for producing cytosolic acetyl-CoA, these
results suggest that Ad4BP/SF-1 bridges the second gap from
glycolysis to cholesterogenesis.
Discussion
Cell-specific transcription factors have been studied in regard to
their cell-specific functions, and thought to be specialized to reg-
ulate cell-specific genes. However, we previously reported that
Ad4BP/SF-1 regulates housekeeping glycolytic genes, as well as
cell-specific steroidogenic genes9. At that time, we could not
explain why a tissue-specific transcription factor would be involved
in housekeeping metabolic regulation. However, the results of this
study suggest a novel mechanism by which this tissue-specific
transcription factor integrates three distinct metabolic pathways—
glycolysis, cholesterogenesis, and steroidogenesis—into a combined
regulatory unit (Supplementary Fig. 1). ERRα (NR3B1) regulates
genes involved in housekeeping energy metabolism, including
glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phos-
phorylation27–29, whereas NRF2 regulates genes involved in the
pentose phosphate pathway30. Considering their preferential
expression in certain types of cells, these factors might also link
housekeeping and cell-specific metabolism.
Given that Ad4BP/SF-1 is the predominant regulator of cho-
lesterogenic genes in steroidogenic cells, we expected that
expression of Ad4BP/SF-1 and cholesterogenic genes would be
synchronized under specific physiological conditions. We recently
reported that during the differentiation of mouse fetal Leydig cells
from their progenitors, the expression of Ad4BP/SF-1 increases31.
At the same time, the genes involved in glycolysis, the TCA cycle,
oxidative phosphorylation, and steroidogenesis are activated31.
Therefore, we investigated whether the genes newly identified as
Ad4BP/SF-1 targets in this study are activated during differ-
entiation. Similar to the metabolic genes above, the mRNA-seq
data revealed that all cholesterogenic genes, as well as Hummr
and Acly, were markedly up-regulated (Supplementary Fig. 9a).
The up-regulation of cholesterogenic genes was confirmed by
qRT-PCR (Supplementary Fig. 9b). Interestingly, Srebf2 expres-
sion was only slightly increased, by less than 2-fold, whereas
expression of cholesterogenic genes was increased by 2- to 22-fold
(Supplementary Fig. 9a and b). Ad4BP/SF-1 itself was increased
by 17-fold, suggesting that the elevated expression of choles-
terogenic genes during differentiation of fetal Leydig cells is at
least in part due to increased expression of Ad4BP/SF-1.
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FLAG antibody. The immunoprecipitates were subjected to western blotting using antibodies for Ad4BP/SF-1, FLAG, and CREB. CREB was used as a
negative control. Full blot images are shown in Supplementary Fig. 10. NE nuclear extract. c Purified HA-SREBP-2 and FLAG-Ad4BP/SF-1 were mixed, and
then immunoprecipitated with anti-FLAG antibody. The immunoprecipitate was subjected to western blotting with anti-HA antibody to examine whether
HA-SREBP-2 was co-immunoprecipitated. d A model of cholesterogenic genes regulation is illustrated. Ad4BP/SF-1 possibly regulates the cholesterogenic
genes by two ways. Ad4BP/SF-1 directly binds to cholesterogenic genes and then regulates the genes possibly in cooperation with SREBP-2. Besides,
Ad4BP/SF-1 indirectly regulates cholesterogenic genes through Srebf2 gene regulation
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Although the liver is the principal organ involved in de novo
synthesis of cholesterol from acetyl-CoA, most cell types,
including adrenal cortex and testicular steroidogenic cells, have
the ability to synthesize cholesterol32,33. The whole cholestero-
genic pathway consists of multiple reactions executed by 20
enzymes. All genes encoding these enzymes have been regulated
by SREBP-211. Our investigation of the ChIP-seq data reported
by Seo et al.14 revealed the accumulation of SREBP-2 near the
transcription initiation sites (putative promoter regions) of all
cholesterogenic genes, arguing in favor of the orchestrated reg-
ulation of all cholesterogenic genes by SREBP-2.
Our study implicates Ad4BP/SF-1, originally identified as the
principal transcriptional regulator of steroidogenic genes, in con-
trol of cholesterogenic gene expression via regulation of Srebf2
(encoding SREBP-2) and/or direct binding to the cholesterogenic
genes themselves. Together, unlike hepatocytes, in which Ad4BP/
SF-1 is not expressed, in steroidogenic cells cholesterogenic genes
are regulated both by Ad4BP/SF-1 and SREBP-2. Because the
demand for cholesterol is augmented in steroidogenic cells upon
stimulation by pituitary hormones4, these cells may be uniquely
equipped to meet this demand. Indeed, it was reported that Scarb1,
which encodes high-density lipoprotein (HDL) receptor respon-
sible for cholesterol incorporation, is directly regulated by Ad4BP/
SF-118. Our mRNA-seq result also suggested that low-density
lipoprotein as well as HDL receptor genes, but not the genes
required for cholesterol excretion (Abca1 and Abcg1), are regulated
by Ad4BP/SF-1. Taken together, by participating in the regulation
of cholesterogenesis and perhaps cholesterol incorporation,
Ad4BP/SF-1 provides an efficient mechanism for meeting the
particular demand of cholesterol in the steroidogenic cells.
Steroidogenic cells do not store large amounts of steroids.
Therefore, to secrete steroids upon stimulation, they must rapidly
synthesize steroids by coordinating multiple routes that supply
the materials for synthesis. Steroidogenic reactions consume
NADPH, which is synthesized by multiple enzymes. Among
them, malic enzyme and methylenetetrahydrofolate dehy-
drogenase make a significant contribution to NADPH synth-
esis34,35. Our recent study demonstrated that the genes encoding
the enzymes mentioned above are direct target genes of Ad4BP/
SF-136. In addition, our previous study implicated Ad4BP/SF-1 in
glycolytic gene regulation9. Glycolysis produces ATP, which is
required for cholesterogenesis and for synthesis of cytosolic
acetyl-CoA, mediated by ATP citrate lyase. Therefore, it is likely
that glycolysis and cholesterogenesis are coupled by Ad4BP/SF-1
to balance the supply and the demand for ATP. Steroidogenesis is
the most critical and specific function of steroidogenic cells.
Together with our previously published results, the findings of
this study suggest that Ad4BP/SF-1 orchestrates distinct
metabolic pathways to supply the building blocks for ster-
oidogenesis so that steroidogenic cells can accomplish their par-
ticular function (Supplementary Fig. 1).
In light of the possibility that Ad4BP/SF-1 might regulate
glycolysis, cholesterogenesis, and steroidogenesis, as a unit, we
noticed two gaps between these metabolic pathways. The first gap
is between cholesterol trafficking from the endoplasmic reticula,
where cholesterogenesis terminates, to the mitochondria, where
steroidogenesis starts. Although not all components of the
machinery have been identified, a recent study found that a
principal component, HUMMR (also referred to as MGARP or
OSAP), is critical for cholesterol transfer to the mitochondrial
outer membrane24. Here, we showed that Hummr is regulated by
Ad4BP/SF-1, suggesting that Ad4BP/SF-1 bridges the gap
between cholesterogenesis and steroidogenesis.
As for the second gap, between glycolysis and cholesterogen-
esis, we identified Acly as a target gene of Ad4BP/SF-1. Acetyl-
CoA synthesized by ACLY can be used for lipogenesis, as well as
cholesterogenesis. Therefore, Acly may act downstream of both
lipogenic and cholesterogenic regulation. Indeed, SREBP-1a and
SREBP-2, which predominantly regulate the genes responsible for
lipogenesis and cholesterogenesis, respectively, regulate Acly by
binding to an SREBP-binding sequence in the promoter26.
Therefore, Ad4BP/SF-1 and SREBP-2 together could bridge the
gap between glycolysis and cholesterogenesis.
To our knowledge, our study provides the first example, where
a single transcription factor can orchestrate housekeeping and
cell-specific metabolism, enabling cells to effectively perform their
particular functions.
Methods
Cell culture. Y-1 cells derived from a mouse adrenocortical tumor were grown in
Dulbecco’s modified Eagle's medium (DMEM) (Wako, Tokyo, Japan) supple-
mented with 10% fetal bovine serum (FBS) and 1× penicillin-streptomycin (Invi-
trogen, Carlsbad, CA, USA) on collagen type I coated dishes (Iwaki, Tokyo, Japan).
Mouse testicular Leydig cells were cultured in DMEM supplemented with 10% FBS
and 1× penicillin–streptomycin on collagen type I coated dishes. HeLa cells derived
from human cervical adenocarcinoma were grown in DMEM supplemented with
10% FBS and 1× penicillin–streptomycin.
Isolation of Leydig cells. Leydig cells were isolated from mouse testes by Percoll
density gradient centrifugation as previously described37. Briefly, testes harvested
from ten 9-week-old male ICR mice were decapsulated and incubated for 10 min at
34 °C with gentle stirring with DMEM supplemented with 0.1% bovine serum
albumin (BSA) (Roche, Basel, Swiss), 100 U/ml penicillin, 100 μg/ul streptomycin,
0.025% soybean trypsin inhibitor (Sigma-Aldrich, St. Louis, MO, USA), and 0.5
mg/ml collagenase (Invitrogen), followed by filtration through a 70-μm cell strainer
(BD Bioscience, Franklin Lakes, NJ, USA). The testicular cells were centrifuged in a
discontinuous density gradient of Percoll (20, 30, 50, and 60%, GE Healthcare,
Little Chalfont, UK) at 25,000 × g for 45 min at 4 °C. Leydig cells forming a thick
band between the 30 and 50% layers were recovered and seeded onto collagen type
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I coated dishes. Unattached cells, such as germ line cells, were washed out with
phosphate-buffered saline (PBS) 4 h after seeding.
Knockdown of Ad4BP/SF-1 and Srebf2. For knockdown of Ad4BP/SF-1, we used
two distinct small interfering RNAs (siRNAs) to exclude a possible off-target effect.
Y-1 cells were transfected for 6 h with siRNA duplexes (Mission siRNA:
Mm_Nr5a1_1635, 5′-CCUUUAUCUCCAUUGUCGATT-3′ (#1635);
Mm_Nr5a1_1636, 5′-CAUUACACGUGCACCGAGATT-3′ (#1636); Sigma-
Aldrich) using Lipofectamine RNAiMAX (Invitrogen) for 6 h. The medium was
replaced, and the cells were cultured for an additional 48 h. The results obtained
with siRNA #1635 are provided in the main text (Fig. 1a, b, Fig. 2c, Fig. 3a, b, and
Fig. 4a, d, f), whereas those obtained with siRNA #1636 are provided in Supple-
mentary Fig. 2b, 4b, 6b, 6c, and 8d. A control siRNA (Stealth RNAi Negative
Control Medium GC Duplex, Invitrogen) was used as a negative control.
For knockdown of Ad4BP/SF-1 in Leydig cells, siRNA duplex (stealth RNAi™;
Nr5a1-MSS240945, 5′-ACAAGGUGUAAUCCAACAGGGCAGC-3′; Invitrogen)
was transfected for 4 h after the cells recovered by Percoll centrifugation were
plated. The culture medium was replaced, and the cells were cultured for an
additional 39 h. A control siRNA (Stealth RNAi Negative Control Medium GC
Duplex, Invitrogen) was used as a negative control.
For the knockdown of Srebf2, Y-1 cells were transfected with siRNA duplex
(stealth RNAi™; Srebf2-MSS277288, 5′-GGCTTCTTGGCTAGCTACTTCTTAA-
3′, Invitrogen) for 6 h, and then cultured for 48 h.
RNA-seq. Poly-A+ RNA was prepared from siAd4BP/SF-1-treated or siControl-
treated Y-1 cells using oligo(dT) magnetic beads. The mRNA-seq library was
prepared using NEBNext® Ultra™ Directional RNA Library Prep kit for Illumina®
(NEB, Ipswich, MA, USA). After the quality of the library was validated on an
Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA), the
samples were subjected to sequencing with a next-generation sequencer
(HiSeq1500, Illumina, San Diego, CA, USA).
Total RNA was prepared from siAd4BP/SF-1-treated or siControl-treated
Leydig cells using the RNeasy Mini kit (Qiagen, Hilden, Germany). Then,
ribosomal RNAs were removed from the total RNA using the Ribo-zero rRNA
removal kit (Illumina). RNA-seq libraries were prepared from the rRNA-depleted
RNAs using the Tru-Seq RNA sample prep kit v2 (Illumina). After the library
quality was validated on an Agilent Bioanalyzer 2100, the RNA-seq libraries were
subjected to sequencing on an Illumina GAIIx. The RNA-seq reads were aligned to
the reference mouse genome sequence, UCSC mm10, using TopHat version 2.0.13
with the default parameters38. Cufflinks (version 2.2.1) was then used with default
parameters to assemble the transcripts and calculate fragments per kilobase of
transcript per million mapped fragments39.
Quantitative RT-PCR. Total RNAs were prepared from Y-1 and Leydig cells
treated with siAd4BP/SF-1 or siControl. cDNAs were synthesized from the RNAs
using M-MLV reverse transcriptase (Invitrogen), and then subjected to qRT-PCR.
Real-time PCR was performed on a CFX96 instrument (Bio-Rad, Hercules, CA,
USA) using SYBR Select master mix (Applied Biosystems). Primers used for qRT-
PCR are listed in the Supplementary Data 1. β-Actin (Actb) was used as a control.
Chromatin immunoprecipitation-quantitative PCR. ChIP was performed
according to the previously described procedure9. Briefly, 2.0 × 107 Y-1 or Leydig
cells were fixed with 1% formaldehyde for 5 min at room temperature, and then
glycine was added to a final concentration of 125 mM to stop the crosslinking
reaction. Then, the fixed cells were lysed with 2 ml ChIP lysis buffer (50 mM Tris-
HCl, pH 8.0, 10 mM EDTA, 1% sodium dodecyl sulfate (SDS)), followed by
sonication (UCD-300 Bioruptor, Diagenode, Belgium) at 4 °C. After dilution of
SDS by addition of 9 volumes of dilution buffer (20 mM Tris-HCl, pH 8.0, 2 mM
EDTA, 150 mM NaCl, 1% Triton X-100), the sheared chromatin was subjected to
immunoprecipitation with 2 μg of anti-Ad4BP/SF-1 antibody previously produced
by ourselves40. Normal rabbit IgG was used as a negative control for the immu-
noprecipitation. The immunoprecipitates were collected using Dynabeads® with
Protein A (Life Technologies, Carlsbad, CA, USA), and then sequentially washed
three times with 700 μl ChIP-radioimmunoprecipitation assay (RIPA) buffer (50
mM Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.1% SDS, 0.5% NP-40), three
times with 700 μl high-salt ChIP-RIPA buffer (50 mM Tris-HCl, pH 8.0, 5 mM
EDTA, 500 mM NaCl, 0.1% SDS, 0.5% NP-40), three times with 700 μl LiCl buffer
(10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 250 mM LiCl, 0.1% NP-40), and once
with 700 μl TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA), all at room tem-
perature. Finally, the chromatin fragments were eluted from the beads with 100 μl
elution buffer (0.1 M NaHCO3, 1% SDS, 10 mM dithiothreitol). After the crosslinks
were reversed by heating at 65 °C for 16 h, DNA fragments were purified using the
QIAquick PCR Purification kit (Qiagen). The purified DNAs were subjected to
real-time PCR using primer sets listed in Supplementary Data 1. Because ChIP-seq
showed that Ad4BP/SF-1 does not bind to exon 7 of the Star gene, this region was
used as a negative control in ChIP-qPCR.
ChIP-sequence. The DNA fragments prepared as described above were used to
construct a ChIP-seq library using the NEBNext DNA sample prep master mix set 1
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Fig. 5 Regulation of Hummr by Ad4BP/SF-1. a The expression of Hummr in
Ad4BP/SF-1 knockdown or control Y-1 cells was examined by qRT-PCR. *p <
0.05. n= 3. b Ad4BP/SF-1 ChIP peaks at the Hummr gene in Y-1 and Leydig
cells in the presence or absence of cAMP are shown. The ChIP peaks are
enclosed by a red square. c Accumulation of Ad4BP/SF-1 to the ChIP peak of
Hummr gene was confirmed by ChIP-qPCR. *p < 0.05. n= 3. a, c Average
values and SDs are shown. The average value of the control was normalized
to 1.0. d A luciferase reporter gene, Hummr-Luc, was constructed with the
genome fragments where Ad4BP/SF-1 was accumulated (gray square) and
the promoter of Hummr gene (white square). Ovals represent potential
Ad4BP/SF-1-binding sites. The reporter was transfected into Y-1 cells with
siAd4BP/SF-1 or siControl. Average values and SDs of the luciferase activities
are indicated. The average value in the absence of siRNA was normalized to
1.0. *p < 0.05. n= 3. e Effects of Ad4BP/SF-1 overexpression on Hummr-Luc
was examined. The reporter was transfected into HeLa cells with increasing
amounts of the expression vector for Ad4BP/SF-1. Average values and SDs
of luciferase activities are indicated. The average value for pGL3 basic in the
absence of the expression vector was normalized to 1.0. n= 3. f Levels of
mitochondrial cholesterol in control, Ad4BP/SF-1 knockdown, and Hummr-
overexpressing Ad4BP/SF-1 knockdown Y-1 cells. Average values and SDs are
shown. *p < 0.05. n= 5
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(NEB) and DNA Sample Prep kit, oligo only (Illumina). Adaptor-ligated DNA
fragments (200–500 bp) were recovered and used for the following steps. After the
quality of the library was validated on an Agilent Bioanalyzer 2100 (Agilent Tech-
nology), the ChIP-seq library was subjected to sequencing on the Illumina GAIIx
platform. ChIP-seq reads were mapped to the reference mouse genome (mm10)
using Bowtie41 (version 0.12.7), allowing up to three mismatches. Multiple-hit reads
were excluded, and only reads uniquely mapped to the reference mouse genome were
subjected to further analysis. To identify peaks and regions of Ad4BP/SF-1 enrich-
ment, uniquely mapped reads were analyzed using MACS (Model-based Analysis for
ChIP-Seq)42 program version 1.4.2 with the option “--nomodel”. The threshold P
values for enriched regions of Ad4BP/SF-1 were set to 10−3.
Luciferase reporter gene assay. Luciferase reporter genes were constructed using
the pGL3 basic vector (Promega, Madison, WI, USA) with upstream regions and
the regions where Ad4BP/SF-1 was found to be accumulated by ChIP-seq (ChIP-
peak regions). For construction of Fdps-Luc, Fdft1-Luc, Msmo1-Luc, Dhcr24-Luc,
Hummer-Luc, and Acly-Luc, the ChIP-peak regions from −6051 to −6631,
+27,724 to +28,080, +15,849 to +16,204, −607 to +29, +4581 to +5035, and
+13,930 to +14,290 bp, respectively, and 5′ upstream regions from −240 to +50,
−311 to +20, −217 to +26, −607 to +29, −1864 to +33, and −1295 to +118 bp,
respectively, were used. Structures of the reporters are illustrated in Fig. 2c, Fig. 4d,
and Supplemenrary Fig. 8d. Gray, white, and black rectangles represent ChIP-peak
regions, promoter regions, and luciferase genes, respectively. Ovals represent
locations of potential Ad4BP/SF-1-binding sites7. In the Dhcr24 gene, the ChIP
peak overlapped with the promoter region.
Y-1 cells were plated on 24-well plates (Iwaki, Tokyo, Japan) at a density of 1.5 ×
105 cells per well. Fdps-Luc, Fdft1-Luc, Msmo1-Luc, and Dhcr24-Luc (10 ng) were
transfected with siAd4BP/SF-1 (#1635) or siControl using Lipofectamine® 2000
transfection reagent (Invitrogen) (Fig. 2c). Hummr-Luc and Acly-Luc (10 ng) were
transfected with siAd4BP/SF-1 (#1635), siAd4BP/SF-1 (#1636), or siControl into Y-1
cells (Fig. 4d and Supplementary Fig. 6c and 8d). In the experiments shown in Fig. 2d
and Supplementary Fig. 8e, 1.5 × 105 HeLa cells were cultured on 24-well plates
(Iwaki), and then pGL3 basic vector, Fdps-Luc, Fdft1-Luc, Msmo1-Luc, Dhcr24-Luc,
and Acly-Luc (10 ng) were transfected along with increasing amounts of Ad4BP/SF-1
expression plasmid (25 or 100 ng)43. pGL3 basic vector and Hummr-Luc (10 ng)
were transfected along with increasing amounts of Ad4BP/SF-1 expression plasmid
(25, 100, or 300 ng) (Fig. 4e). In Fig. 2e, Fdps-Luc, Msmo1-Luc, and Dhcr24-Luc (10
ng) were transfected into Y-1 cells along with expression plasmids of Ad4BP/SF-1
(300 ng) and transcriptionally active SREBP-2 (1-481) (100 ng)44. pCMV-SPORT-
βgal (Invitrogen) was used as an internal control. Six hours after transfection, the
medium was replaced. Forty-eight hours after transfection, the cells were harvested,
and luciferase and β-galactosidase activities were determined.
Preparation of nuclear extract from Y-1 cells. Y-1 cells (4.0 × 107) were har-
vested and suspended in 500 μl of hypotonic buffer (10 mM HEPES-KOH, pH 7.9,
1.5 mM MgCl2, 10 mM KCl) supplemented with phenylmethylsulfonyl fluoride
(PMSF) (Nacalai Tesque, Kyoto, Japan) and benzamidine (Nacalai Tesque). The
cells were swelled on ice for 5 min, and then homogenized using a 24-gauge needle
(Terumo, Tokyo, Japan). Nuclei were collected by centrifugation at 900 × g, for 15
min at 4 °C. The pelleted nuclei were suspended with 200 μl 50 mM HEPES, pH
7.8, 10 mM NaCl, 0.1 mM EDTA, 5 mM MgCl2, 2% glycerol, and then the same
volume of 50 mM HEPES, pH 7.8, 800 mM NaCl, 0.1 mM EDTA, 5 mMMgCl2, 2%
glycerol was added. To extract nuclear proteins, the sample was kept on ice for 30
min. Thereafter, the sample was centrifuged (20,000 × g, 4 °C, 30 min), and the
supernatant was collected as nuclear extract. The nuclear extract was dialyzed
overnight with 1 L of binding buffer (see next paragraph for details) supplemented
with PMSF and benzamidine, and then used for the subsequent experiments.
Physical interaction between Ad4BP/SF-1 and SREBP-2. cDNAs encoding full-
length Ad4BP/SF-1 or N-terminal region of SREBP-2 (1-481; transcriptionally
active form) were cloned into pFastBac plasmids (Thermo Fisher Scientific, Wal-
tham, MA, USA). FLAG-Ad4BP/SF-1, FLAG-SREBP-2, and HA-SREBP-2 were
expressed using the Baculovirus Expression System (Thermo Fisher Scientific) in
Sf21 cells according to the manufacturer’s protocol. The cells were lysed in 20 mM
Tris-HCl (pH 8.0), 400 mM KCl, 10% glycerol, 5 mM MgCl2, and 0.1% Tween-20.
The FLAG-tagged or HA-tagged proteins were immunopurified with anti-FLAG
M2 antibody affinity agarose (Sigma-Aldrich) or anti-HA (clone 12CA5, Abcam,
Cambridge, UK) antibody-conjugated agarose beads, and then eluted with 0.25 mg/
ml 3× FLAG peptide (Sigma-Aldrich) or with 0.25 mg/ml 3× HA-tag peptide
(Cosmo Bio Co., Ltd., Tokyo, Japan), respectively45,46. In pull-down experiments
(Fig. 2f), FLAG-SREBP-2 (300 ng) was incubated overnight at 4 °C with the nuclear
extract prepared from Y-1 cells in 1 ml binding buffer (50 mM HEPES-KOH, pH
7.4, 150 mM NaCl, 1 mM EDTA, 0.1% NP-40) supplemented with PMSF and
benzamidine. FLAG-SREBP-2 (1-481) and its interactants were immunoprecipi-
tated with anti-FLAG antibody-conjugated magnetic beads (Sigma-Aldrich), and
then the beads were sequentially washed three times with 700 μl low-salt washing
buffer (50 mM HEPES-KOH, pH 7.4, 150 mM NaCl, 0.1% NP-40), three times
with 700 μl high-salt washing buffer (50 mM HEPES-KOH, pH 7.4, 300 mM NaCl,
0.1% NP-40), and once with 700 μl PBS. Finally, the immunoprecipitates were
eluted from the beads with 15 μl elution buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 500 μg/ml FLAG peptide). Eluates and inputs were subjected to SDS-
polyacrylamide gel electrophoresis followed by western blotting using antibodies
against Ad4BP/SF-1 (1/1000), FLAG (1/1000, Nacalai Tesque), or CREB (cAMP-
responsive element binding protein, 1/1000, Millipore, Billerica, MA, USA). CREB
was used as a negative control. For in vitro binding assays (Fig. 2g), HA-SREBP-2
(1-481) (300 ng) and FLAG-Ad4BP/SF-1 (300 ng) were incubated overnight at 4 °C
in 1 ml binding buffer. Following the same washing and elution procedures
described for the pull-down experiment above, western blotting was performed
using antibody against HA (1/1000) or FLAG (1/1000).
Measurement of de novo cholesterol synthetic activity. De novo cholestero-
genic activity was measured as described previously47,48. Y-1 cells were treated with
siAd4BP/SF-1 (#1635) or siControl for 48 h, and then incubated for 1 h at 37 °C in
a serum-free medium containing [1,2-14C]acetate (PerkinElmer, Boston, MA,
USA), 50 μM aminoglutethimide (Sigma-Aldrich) and 2 μg/ml 58-035 (ACAT2;
acyl-CoA cholesterol acyltransferase inhibitor) (Sigma-Aldrich). Total lipid frac-
tion containing cholesterol was extracted with chloroform/methanol (2:1, v/v), and
then separated by thin-layer chromatography on a silica gel using benzene-
ethylacetate (2:3, v/v) as a solvent. The radioactivities of the spots for free and
esterified cholesterol, visualized with iodine vapor, were determined by liquid
scintillation counting. [1,2-14C]acetate incorporation into cholesterol was expres-
sed as cpm/mg protein/h.
Quantification of cholesterol and related metabolites. Y-1 cells were treated
with siAd4BP/SF-1 (#1635) or siControl for 48 h, and then whole cells or mito-
chondria isolated from the cells were suspended in 0.2 ml methanol at 4 °C. The
suspension was sonicated (2 × 20 s pulses, separated by a 30-s interval) on a
Bioruptor® Plus (Diagenode). Thereafter, they were centrifuged at 15,000 rpm for 5
min at 4 °C to eliminate methanol-insoluble cellular components. The supernatant
(methanol soluble fraction) was recovered and evaporated to remove methanol.
Gas chromatography-mass spectrometry analysis was performed using an Agilent
6890 Plus gas chromatograph interfaced with a single-quadrupole Agilent 5975C
MSD (Agilent) as previously described49.
Statistics. All experiments were performed in at least three biologically indepen-
dent replicates. Data are represented as average and standard deviation (SD). The
numbers of the experimental replicates are indicated with “n” in figure legends.
Statistical significance was examined using a two-tailed Student’s t test.
Data availability. mRNA-seq data have been deposited in DDBJ under the
accession code DRA005961 (Y-1 cells) and DRA005963 (Leydig cells) (http://trace.
ddbj.nig.ac.jp/DRASearch/).
ChIP-seq data have been deposited in GEO under the accession code
GSE106955 (https://www.ncbi.nlm.nih.gov/geo/).
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